Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JPM25: The companies and trends we're watching
biosimilars
Payers
Blue Shield to buy Humira biosimilar directly from manufacturer
The insurer is making one of its first major moves as part of the Pharmacy Care Reimagined model.
Paige Minemyer
Oct 2, 2024 3:00pm
Optum axes Humira from some of its preferred formularies: report
Sep 10, 2024 4:00pm
Accredo to make Stelara biosimilar available at $0 out-of-pocket
Sep 5, 2024 6:00am
Boehringer, GoodRx team to boost access to Humira biosimilars
Jul 18, 2024 3:00pm
AHIP 2024: The hurdles to widespread biosimilar adoption
Jun 12, 2024 5:30am
Evernorth's Accredo to offer Humira biosim at $0 out-of-pocket
Apr 25, 2024 4:30pm